2 doctors weighed in:

Hello, Shall I allways have Zometa and Herceptin (trastuzumab) for HER 2 breast cancer bone metastasis? OR, is Zometa with Femara enough? Thanks a lot

2 doctors weighed in
Dr. Le Wang
Internal Medicine
1 doctor agrees

In brief: Her2-pos Breast Ca

Herceptin (trastuzumab) is indicated for Her2-pos metastatic BC.
Duration of therapy in metastatic setting is not well defined. Usually it continues as long as it works or discontinued due to toxicity. Zometa is indicated for bone metastasis in most solid tumors. It carries a risk for osteonecrosis of jaw. Usually it is stopped after 2 yrs if not earlier. Femara is for post-menopausal BC who has positive ER/PR.

In brief: Her2-pos Breast Ca

Herceptin (trastuzumab) is indicated for Her2-pos metastatic BC.
Duration of therapy in metastatic setting is not well defined. Usually it continues as long as it works or discontinued due to toxicity. Zometa is indicated for bone metastasis in most solid tumors. It carries a risk for osteonecrosis of jaw. Usually it is stopped after 2 yrs if not earlier. Femara is for post-menopausal BC who has positive ER/PR.
Thank
Get help from a real doctor now
Dr. Dennis Higginbotham
Board Certified, Obstetrics & Gynecology
29 years in practice
49M people helped
Continue
100,000 doctors available